Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2007
06/07/2007US20070129404 kinase enzyme inhibitor 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, useful as a drug treating eye diseases including glaucoma
06/07/2007US20070129399 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
06/07/2007US20070129390 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2007US20070129381 Pharmaceutically active pyrrolidine ester derivatives
06/07/2007US20070129375 6-Substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors
06/07/2007US20070129374 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
06/07/2007US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
06/07/2007US20070129367 Pyridine derivatives as cb2 receptor modulators
06/07/2007US20070129363 N-type calcium channel antagonists for the treatment of pain
06/07/2007US20070129361 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
06/07/2007US20070129358 Sbstituted chroman derivatives, processes for their preparation and their use as antiinflammatory agents
06/07/2007US20070129357 Novel crystals of fluorobenzamide derivative
06/07/2007US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases
06/07/2007US20070129346 Melanocortin receptor agonists
06/07/2007US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia
06/07/2007CA2636314A1 Arylmethylene urea derivative and use thereof
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2631826A1 Acid addition salt of dihydropyridine derivative
06/07/2007CA2631746A1 Urea compounds useful in the treatment of cancer
06/07/2007CA2631232A1 Novel vinylogous acids derivatives
06/07/2007CA2630410A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
06/07/2007CA2630314A1 1,5-substituted indol-2-yl amide derivatives
06/07/2007CA2630307A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
06/07/2007CA2630270A1 5-substituted indole-2-carboxamide derivatives
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/07/2007CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007CA2605073A1 Substituted indole compounds having nos inhibitory activity
06/06/2007EP1792897A2 Intercalators having affinity for DNA and methods of use
06/06/2007EP1791833A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
06/06/2007EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
06/06/2007EP1791831A2 Methods of treating diseases and disorders by targeting multiple kinases
06/06/2007EP1791830A1 Diaminotriazole compounds useful as protein kinase inhibitors
06/06/2007EP1791829A1 Heteroaroyl-substituted serine amides utilized as herbicides
06/06/2007EP1791828A1 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates
06/06/2007EP1791827A1 4-heteroarylmethyl substituted phthalazinone derivatives
06/06/2007EP1791826A2 Crystalline polymorph of pipendoxifene hydrochloride monohydrate
06/06/2007EP1613313B1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
06/06/2007EP1230248B1 Transition metal complexes attached to a polymer via a flexible chain
06/06/2007EP1187833B1 Method of producing thiamethoxam
06/06/2007CN1976924A Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
06/06/2007CN1976923A Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
06/06/2007CN1976922A 4-amino-5-cyanopyrimidine derivatives
06/06/2007CN1976921A Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
06/06/2007CN1976920A N-type calcium channel blockers
06/06/2007CN1976919A Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
06/06/2007CN1976918A 4,5-disubstituted-2-aryl pyrimidines
06/06/2007CN1976917A Pyridine derivatives of alkyl oxindoles functioning as active substance against 5-HT7 receptor
06/06/2007CN1976916A Selected CGRP - antagonists, process for preparing them and their use as pharmaceutical compositions
06/06/2007CN1976915A Hiv整合酶抑制剂 Hiv integrase inhibitors
06/06/2007CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
06/06/2007CN1976906A Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
06/06/2007CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof
06/06/2007CN1976904A Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
06/06/2007CN1976707A 3-aminocyclopentanecarboxamides as modulators of chemotactic factor receptors
06/06/2007CN1976706A Inhibition of FGFR3 and treatment of multiple myeloma
06/06/2007CN1976586A Piperazin derivatives and their use in controlling pests
06/06/2007CN1976585A Substituted pyridazine carboxamides and derivatives thereof
06/06/2007CN1976584A Chemical compounds
06/06/2007CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
06/06/2007CN1974566A Chiral ionic compound containing pyrrolidinyl radical and its prepn and application
06/06/2007CN1319966C Novel benzoimidazole derivatives useful as antiproliferative agents
06/06/2007CN1319965C 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides
06/06/2007CN1319950C 3-substituted-4-pyrimidone derivatives
06/06/2007CN1319945C Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
06/05/2007USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2
06/05/2007US7227025 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine
06/05/2007US7227024 Method for the synthesis of a benzimidazole compound
06/05/2007US7226942 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
06/05/2007US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
06/05/2007US7226933 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
06/05/2007US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents
06/05/2007US7226927 Administering 2-aryl-4- arylaminopyrimidine and analogs thereof, for therapy of disorder responsive to the induction of apoptosis in an animal suffering therefrom
06/05/2007US7226925 Compounds, their use and preparation
06/05/2007US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease
06/05/2007US7226920 Aminotriazole compounds useful as inhibitors of protein kinases
06/05/2007CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion
06/05/2007CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
05/2007
05/31/2007WO2007062342A1 Heterocyclic cetp inhibitors
05/31/2007WO2007061731A1 Method for making nanostructured surfaces
05/31/2007WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
05/31/2007WO2007060409A1 L-alanine derivatives
05/31/2007WO2007060408A2 L-phenylalanine derivatives and their use as integrin antagonists
05/31/2007WO2007060249A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor
05/31/2007WO2007060110A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
05/31/2007WO2007060027A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
05/31/2007WO2007059963A1 F,g,h,i and k crystal forms of imatinib mesylate
05/31/2007WO2007059871A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia
05/31/2007WO2007059610A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
05/31/2007WO2007042669A3 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics
05/31/2007WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof
05/31/2007WO2007041061A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
05/31/2007WO2007037543A9 Biarylamide derivative
05/31/2007WO2007037534A9 2-heteroaryl-substituted indole derivative
05/31/2007WO2007036771A3 Pantoprazole free acid form iii
05/31/2007WO2007036718A3 Compounds which have activity at m1 receptor and their uses in medicine
05/31/2007WO2007024294A3 Certain substituted ureas, as modulators of kinase activity
05/31/2007WO2007017289A3 Acyltryptophanols for fertility control
05/31/2007WO2007014851A3 Indol-3-yl-carbonyl-piperidin and piperazin derivatives
05/31/2007WO2006058700A8 Acetamide compounds as fungicides